DBX: Executive (Sarah Schubach) reports multiple 10b5-1 sales (03–05/2026)
Rhea-AI Filing Summary
DBX filing reports multiple restricted-share sales by Sarah Schubach under a 10b5-1 plan. The notice lists a Restricted Stock Unit sale dated 05/15/2026 and a series of 10b5-1 sales on 03/02/2026, 03/16/2026, 03/31/2026, 04/15/2026, 04/30/2026, and 05/19/2026. The filing provides per‑trade numeric entries (for example, 1,306 and $36,750.84 on 05/19/2026). These rows reflect reported dispositions under established trading instructions rather than new corporate actions.
Positive
- None.
Negative
- None.
Insights
TL;DR: Multiple 10b5-1 sales by an executive are reported across March–May 2026.
What happened: The excerpt lists a Restricted Stock Unit entry and seven 10b5-1 sales by Sarah Schubach with dated entries from 03/02/2026 through 05/19/2026. The filing shows per‑trade numeric rows such as 1,306 and $36,750.84 for the 05/19/2026 line.
Context and implications: These rows are consistent with programmed dispositions under a 10b5-1 plan; timing and amounts follow the plan's instructions. Cash‑flow treatment and total holdings after these transactions are not shown in the excerpt. Subsequent filings or fuller tables may list aggregated proceeds or remaining holdings.